Meta facebook tracking pixel

Listen Now

Topics Covered

  • Overview of Follicular Lymphoma, in the Context of COVID-19 & Its Variants
  • Treatment Options for Newly Diagnosed
  • Treatment Options for Relapsed/Refractory Disease
  • Clinical Trial Updates
  • How Research Contributes to Your Treatment Options
  • New & Emerging Treatments
  • Factors that May Affect Treatment Planning
  • Preventing & Managing Treatment Side Effects, Symptoms & Discomfort
  • Tips to Improve Communicating with Your Health Care Team
  • The Importance of Communication, in the Context of COVID-19 & Its Variants, with Telehealth/Telemedicine Appointments
  • Guidelines to Prepare for Telehealth/Telemedicine Appointments, including Technology, Prepared List of Questions & Discussion of OpenNotes
  • Key Questions to Ask Your Health Care Team about Quality-of-Life Concerns
  • Practical & Psychosocial Support to Cope with Follicular Lymphoma
  • Questions for Our Panel of Experts

Our Panel of Experts


Peter Martin, MD, MS

Chief Lymphoma Program, Associate Professor of Medicine, Weill Cornell Medicine, Associate Attending Physician, NewYork-Presbyterian Hospital


Jonathon B. Cohen, MD, MS

Associate Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine, Co-Director, Lymphoma Program, Chair, Data and Safety Monitoring Committee, Winship Cancer Institute of Emory University


Carolyn Messner, DSW, BCD, FAPOS, FAOSW

Senior Director of Education and Training, CancerCare


You can download the brochure for this workshop Download button

Workshop Date

This workshop was originally recorded on March 28, 2022.

Search by:



The information presented in this workshop is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top

Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.